Journal of Clinical Endocrinology & Metabolism, Vol 74, 1436-1440, Copyright © 1992 by Endocrine Society

ARTICLES

Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia

EW Seely, RJ Wood, EM Brown and SW Graves
Endocrine-Hypertension Division, Brigham and Women's Hospital, Boston, Massachusetts 02115.

Relative hypocalciuria has been reported in women with preeclampsia. However, there has been no systematic explanation for this finding. We measured serum and urinary calcium and serum calciotropic hormones in third trimester women with preeclampsia (n = 12, gestational hypertension and proteinuria) and with normotensive pregnancies (n = 24) to try to explain these changes. We confirmed that the women with preeclampsia have a relative hypocalciuria (2.9 +/- 0.7 vs. 6.5 +/- 0.2 mmol/day, P less than 0.01). Preeclamptic women also had lower serum ionized calcium than normotensive third trimester pregnant women (1.20 +/- 0.01 vs. 1.26 +/- 0.01 mmol/L, P less than 0.02). Intact PTH levels were significantly higher in preeclamptic women (29.9 +/- 4.3 vs. 15.4 +/- 1.3 ng/L, P less than 0.01) and a significant inverse relationship was observed between PTH and both urine calcium (r = -0.60, P less than 0.0001) and serum ionized calcium (r = -0.36, P less than 0.05). We measured vitamin D metabolites in a subgroup of both normotensive and preeclamptics. Preeclamptic and normotensive pregnant women had equivalent levels of 25-hydroxyvitamin D [25(OH)D]; however, preeclamptics had significantly lower 1,25-dihydroxyvitamin D [1,25- (OH)2D] levels (172.1 +/- 18.5 vs. 219.6 +/- 12.7 pmol/L, P less than 0.05). Lower 1,25-(OH)2D may contribute to suboptimal intestinal absorption of calcium during a time of increased calcium demand resulting in lower ionized calcium, increased PTH, and hypocalciuria in preeclampsia. Abnormalities in calcium homeostasis may contribute to the increased vascular sensitivity documented in preeclampsia.

This article has been cited by other articles:

				L. M. Bodnar, J. M. Catov, H. N. Simhan, M. F. Holick, R. W. Powers, and J. M. Roberts Maternal Vitamin D Deficiency Increases the Risk of Preeclampsia J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3517 - 3522. [Abstract] [Full Text] [PDF]

				M. Shaarawy, S. Zaki, A.-M. Ramzi, M. E. Salem, and A. M. El-Minawi Feto-maternal Bone Remodeling in Normal Pregnancy and Preeclampsia Reproductive Sciences, July 1, 2005; 12(5): 343 - 348. [Abstract] [PDF]

				L. Diaz, C. Arranz, E. Avila, A. Halhali, F. Vilchis, and F. Larrea Expression and Activity of 25-Hydroxyvitamin D-1{alpha}-Hydroxylase Are Restricted in Cultures of Human Syncytiotrophoblast Cells from Preeclamptic Pregnancies J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3876 - 3882. [Abstract] [Full Text] [PDF]

				D. Zehnder, K. N. Evans, M. D. Kilby, J. N. Bulmer, B. A. Innes, P. M. Stewart, and M. Hewison The Ontogeny of 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Expression in Human Placenta and Decidua Am. J. Pathol., July 1, 2002; 161(1): 105 - 114. [Abstract] [Full Text] [PDF]

				A. HALHALI, S. J. WIMALAWANSA, V. BERENTSEN, E. AVILA, C. S. THOTA, and F. LARREA Calcitonin Gene- and Parathyroid Hormone-Related Peptides in Preeclampsia: Effects of Magnesium Sulfate Obstet. Gynecol., June 1, 2001; 97(6): 893 - 897. [Abstract] [Full Text] [PDF]

				A. Halhali, A. R. Tovar, N. Torres, H. Bourges, M. Garabedian, and F. Larrea Preeclampsia Is Associated with Low Circulating Levels of Insulin-Like Growth Factor I and 1,25-Dihydroxyvitamin D in Maternal and Umbilical Cord Compartments J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1828 - 1833. [Abstract] [Full Text]

				E. R. Norwitz and J. T. Repke Preeclampsia Prevention and Management Reproductive Sciences, January 1, 2000; 7(1): 21 - 36. [Abstract] [PDF]

				C. S. Kovacs and H. M. Kronenberg Maternal-Fetal Calcium and Bone Metabolism During Pregnancy, Puerperium, and Lactation Endocr. Rev., December 1, 1997; 18(6): 832 - 872. [Abstract] [Full Text]